دورية أكاديمية
Dynamics of SARS-CoV-2 Antibody Response to CoronaVac followed by Booster Dose of BNT162b2 Vaccine.
| العنوان: | Dynamics of SARS-CoV-2 Antibody Response to CoronaVac followed by Booster Dose of BNT162b2 Vaccine. |
|---|---|
| المؤلفون: | Fonseca MHG, Pinto ACMD, Silva MFS, de Melo ACL, Vasconcelos GS, Dos Santos ER, de Carvalho Araújo FM, de Andrade LOM |
| المصدر: | Emerging infectious diseases [Emerg Infect Dis] 2022 Jun; Vol. 28 (6), pp. 1237-1240. Date of Electronic Publication: 2022 Apr 14. |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1080-6059 (Electronic) Linking ISSN: 10806040 NLM ISO Abbreviation: Emerg Infect Dis Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Atlanta, GA : National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), [1995- |
| مواضيع طبية MeSH: | COVID-19*/prevention & control , Vaccines*, Antibodies, Viral ; Antibody Formation ; BNT162 Vaccine ; COVID-19 Vaccines ; Humans ; SARS-CoV-2 |
| مستخلص: | We evaluated the longitudinal dynamics of antibody response to the SARS-CoV-2 vaccine CoronaVac and the effect of a booster dose of BNT162b2 vaccine. We found a robust antibody response after the second dose of CoronaVac that wanes over time. The response was recovered by BNT162b2, which boosted anti-spike antibody titers. |
| References: | Int J Infect Dis. 2021 Nov;112:40-44. (PMID: 34481967) Front Public Health. 2021 Dec 01;9:778243. (PMID: 34926392) Lancet Infect Dis. 2022 Jan;22(1):56-63. (PMID: 34509185) Genet Mol Biol. 2021 Mar 29;44(1 Suppl 1):e20200320. (PMID: 33818582) Clin Chim Acta. 2021 Jul;518:9-16. (PMID: 33741357) Lancet Reg Health Eur. 2021 Nov;10:100208. (PMID: 34514454) J Med Virol. 2022 Jan;94(1):39-41. (PMID: 34536028) N Engl J Med. 2020 Dec 31;383(27):2603-2615. (PMID: 33301246) Front Immunol. 2019 Jul 31;10:1787. (PMID: 31417562) |
| فهرسة مساهمة: | Keywords: BNT162b2 vaccine; COVID-19; CoronaVac; SARS-CoV-2; antibody response; coronavirus disease; healthcare workers; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccine-preventable diseases; viruses; zoonoses |
| المشرفين على المادة: | 0 (Antibodies, Viral) 0 (COVID-19 Vaccines) 0 (Vaccines) N38TVC63NU (BNT162 Vaccine) |
| تواريخ الأحداث: | Date Created: 20220414 Date Completed: 20220524 Latest Revision: 20220716 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC9155880 |
| DOI: | 10.3201/eid2806.220061 |
| PMID: | 35421324 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!